Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,879 | 87 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $534.96 | 25 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $437.21 | 18 | $0 (2021) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $287.87 | 22 | $0 (2021) |
| Micro-tech Endoscopy USA, Inc. | $176.26 | 6 | $0 (2024) |
| Celltrion USA Inc. | $132.96 | 1 | $0 (2024) |
| Ferring Pharmaceuticals Inc. | $85.96 | 6 | $0 (2021) |
| Intercept Pharmaceuticals, Inc. | $85.80 | 1 | $0 (2019) |
| Gilead Sciences, Inc. | $58.92 | 3 | $0 (2020) |
| Ironwood Pharmaceuticals, Inc | $35.33 | 2 | $0 (2021) |
| Janssen Biotech, Inc. | $16.09 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $300.08 | 7 | ABBVIE INC. ($158.98) |
| 2023 | $167.45 | 9 | ABBVIE INC. ($129.45) |
| 2022 | $82.70 | 5 | ABBVIE INC. ($58.42) |
| 2021 | $344.49 | 13 | Micro-tech Endoscopy USA, Inc. ($118.89) |
| 2020 | $400.53 | 26 | Takeda Pharmaceuticals U.S.A., Inc. ($133.41) |
| 2019 | $458.98 | 26 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($150.81) |
| 2018 | $124.66 | 1 | Takeda Pharmaceuticals U.S.A., Inc. ($124.66) |
All Payment Transactions
87 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $55.79 | General |
| Category: IMMUNOLOGY | ||||||
| 11/01/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $17.84 | General |
| Category: IMMUNOLOGY | ||||||
| 10/10/2024 | Celltrion USA Inc. | ZYMFENTRA (Biological) | Food and Beverage | In-kind items and services | $132.96 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/13/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $34.48 | General |
| Category: IMMUNOLOGY | ||||||
| 08/02/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $25.20 | General |
| Category: IMMUNOLOGY | ||||||
| 06/27/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $25.67 | General |
| Category: IMMUNOLOGY | ||||||
| 02/09/2024 | Micro-tech Endoscopy USA, Inc. | EdgeHog (Device) | Food and Beverage | In-kind items and services | $8.14 | General |
| Category: GI Endoscopy | ||||||
| 11/03/2023 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $28.40 | General |
| Category: IMMUNOLOGY | ||||||
| 09/22/2023 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $19.60 | General |
| Category: IMMUNOLOGY | ||||||
| 08/30/2023 | Micro-tech Endoscopy USA, Inc. | "Entire Product Line" listed Need actual marketed device name(s) (Device) | Food and Beverage | Cash or cash equivalent | $12.12 | General |
| Category: GI Endoscopy | ||||||
| 08/11/2023 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $17.88 | General |
| Category: IMMUNOLOGY | ||||||
| 06/16/2023 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $23.36 | General |
| Category: IMMUNOLOGY | ||||||
| 06/13/2023 | Micro-tech Endoscopy USA, Inc. | Lesion Hunter (Device) | Food and Beverage | Cash or cash equivalent | $13.40 | General |
| Category: GI Endoscopy | ||||||
| 04/28/2023 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $21.60 | General |
| Category: IMMUNOLOGY | ||||||
| 03/28/2023 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $18.61 | General |
| Category: IMMUNOLOGY | ||||||
| 02/16/2023 | Micro-tech Endoscopy USA, Inc. | Lesion Hunter (Device) | Food and Beverage | Cash or cash equivalent | $12.48 | General |
| Category: GI Endoscopy | ||||||
| 12/22/2022 | Micro-tech Endoscopy USA, Inc. | Clips, Snares, Injection Needles (Device) | Food and Beverage | Cash or cash equivalent | $11.23 | General |
| Category: GI Endoscopy | ||||||
| 11/18/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $20.08 | General |
| Category: IMMUNOLOGY | ||||||
| 09/23/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $20.61 | General |
| Category: IMMUNOLOGY | ||||||
| 08/05/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $17.73 | General |
| Category: IMMUNOLOGY | ||||||
| 05/27/2022 | Braintree Laboratories, Inc. | SUTAB (Drug) | Food and Beverage | In-kind items and services | $13.05 | General |
| Category: GI COLON PREP | ||||||
| 12/09/2021 | Micro-tech Endoscopy USA, Inc. | LesionHunter (Device) | Food and Beverage | Cash or cash equivalent | $118.89 | General |
| Category: GI Disposables | ||||||
| 05/18/2021 | Takeda Pharmaceuticals U.S.A., Inc. | MOTEGRITY (Drug) | Food and Beverage | In-kind items and services | $25.16 | General |
| Category: INTERNAL MEDICINE | ||||||
| 05/11/2021 | Ironwood Pharmaceuticals, Inc | Linzess (Drug), GIVLAARI | Food and Beverage | Cash or cash equivalent | $18.71 | General |
| Category: GI | ||||||
| 05/11/2021 | Ferring Pharmaceuticals Inc. | CIMZIA (Drug) | Food and Beverage | In-kind items and services | $11.83 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 654 | 799 | $448,916 | $95,914 |
| 2022 | 20 | 665 | 747 | $442,513 | $103,003 |
| 2021 | 14 | 308 | 338 | $156,852 | $41,815 |
| 2020 | 9 | 211 | 269 | $128,905 | $23,335 |
All Medicare Procedures & Services
63 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Office | 2023 | 81 | 83 | $138,150 | $34,589 | 25.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 123 | 197 | $65,404 | $21,470 | 32.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 98 | 98 | $49,980 | $13,603 | 27.2% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Office | 2023 | 73 | 75 | $111,825 | $10,850 | 9.7% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Office | 2023 | 34 | 35 | $39,100 | $7,434 | 19.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 11 | 11 | $6,820 | $1,638 | 24.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 16 | 18 | $4,086 | $1,425 | 34.9% |
| 45381 | Injection beneath lining of large bowel using a flexible endoscope | Office | 2023 | 12 | 12 | $15,468 | $1,144 | 7.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 16 | 16 | $5,440 | $1,142 | 21.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 53 | 75 | $675.00 | $630.00 | 93.3% |
| 82306 | Vitamin d-3 level | Office | 2023 | 13 | 14 | $2,800 | $406.14 | 14.5% |
| 82728 | Ferritin (blood protein) level | Office | 2023 | 20 | 27 | $2,295 | $358.88 | 15.6% |
| 84466 | Transferrin (iron binding protein) level | Office | 2023 | 19 | 26 | $1,976 | $312.50 | 15.8% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 26 | 36 | $1,044 | $273.96 | 26.2% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 16 | 19 | $1,102 | $196.65 | 17.8% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 11 | 13 | $1,183 | $192.14 | 16.2% |
| 83540 | Iron level | Office | 2023 | 19 | 26 | $1,118 | $158.50 | 14.2% |
| 86140 | Measurement c-reactive protein for detection of infection or inflammation | Office | 2023 | 13 | 18 | $450.00 | $91.44 | 20.3% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Office | 2022 | 73 | 77 | $127,650 | $31,498 | 24.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 107 | 167 | $55,444 | $18,735 | 33.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 85 | 85 | $43,350 | $12,848 | 29.6% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Office | 2022 | 41 | 41 | $45,100 | $9,908 | 22.0% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Office | 2022 | 49 | 50 | $74,350 | $9,070 | 12.2% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Office | 2022 | 30 | 30 | $36,840 | $7,260 | 19.7% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 15 | 15 | $9,300 | $2,748 | 29.6% |
About Jared Macklin
Jared Macklin is a Gastroenterology healthcare provider based in Purchase, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/09/2013. The National Provider Identifier (NPI) number assigned to this provider is 1205279247.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jared Macklin has received a total of $1,879 in payments from pharmaceutical and medical device companies, with $300.08 received in 2024. These payments were reported across 87 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($1,879).
As a Medicare-enrolled provider, Macklin has provided services to 1,838 Medicare beneficiaries, totaling 2,153 services with total Medicare billing of $264,067. Data is available for 4 years (2020–2023), covering 63 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Other Specialties Gastroenterology
- Location Purchase, NY
- Active Since 04/09/2013
- Last Updated 07/08/2021
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1205279247
Products in Payments
- XIFAXAN (Drug) $236.76
- RINVOQ (Biological) $235.01
- Entyvio (Biological) $201.45
- MOTEGRITY (Drug) $151.30
- ZYMFENTRA (Biological) $132.96
- LesionHunter (Device) $118.89
- SKYRIZI (Biological) $111.84
- OCALIVA (Drug) $85.80
- ENTYVIO (Biological) $84.46
- CLENPIQ (Drug) $74.13
- HUMIRA (Biological) $66.43
- TRULANCE (Drug) $51.11
- Humira (Biological) $37.22
- Linzess (Drug) $35.33
- Creon (Drug) $31.12
- Lesion Hunter (Device) $25.88
- Mavyret (Drug) $21.94
- LINZESS (Drug) $16.32
- REMICADE (Biological) $16.09
- CREON (Drug) $15.08
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.